Neprilysin levels at the acute phase of ST-elevation myocardial infarction.
Hugo BernelinNathan MewtonSalim Si-MohamedPierre CroisilleGilles RioufolEric Bonnefoy-CudrazPhilippe DouekNathalie DufayCamille AmazClaire JossanMichel OvizeThomas BochatonPublished in: Clinical cardiology (2018)
NEP serum levels were widely distributed and did not change significantly in the first hours and 1-month period following reperfusion in STEMI patients. There was no significant relationship with markers of infarct size and inflammation, and 1-year adverse outcomes.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- end stage renal disease
- acute myocardial infarction
- newly diagnosed
- ejection fraction
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- patient reported outcomes
- acute ischemic stroke
- left ventricular
- cerebral ischemia
- blood brain barrier